# Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea

> **NCT01355458** · PHASE3 · COMPLETED · sponsor: **Galderma R&D** · enrollment: 260 (actual)

## Conditions studied

- Rosacea

## Interventions

- **DRUG:** CD07805/47 gel
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01355458
- **Lead sponsor:** Galderma R&D
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2011-09
- **Final completion:** 2011-12
- **Target enrollment:** 260 (ACTUAL)
- **Last updated:** 2021-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01355458

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01355458, "Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01355458. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*